Belgian drug developer Galapagos signs a deal worth up to $1.35B with Abbott Laboratories (ABT)...

|About: Abbott Laboratories (ABT)|By:, SA News Editor

Belgian drug developer Galapagos signs a deal worth up to $1.35B with Abbott Laboratories (ABT) for the development and production of an oral drug to treat arthritis and other auto-immune diseases. (PR)